T. Rowe Price U.S. Equity Research ETF
TSPA - ETF AI Analysis
Top Page
T. Rowe Price U.S. Equity Research ETF (TSPA)
TSPA, the T. Rowe Price U.S. Equity Research ETF, earns a solid overall rating largely because its biggest holdings—like Apple, Microsoft, and Alphabet—combine strong financial performance with promising growth in areas such as cloud, AI, and services. These high-quality tech leaders help offset some concerns around premium valuations, mixed technical signals, and company-specific risks like cash flow and leverage at names such as Amazon and Eli Lilly. The main risk factor is the fund’s heavy concentration in large U.S. technology and AI-focused companies, which can increase sensitivity to market swings in that sector.
TSPA vs. SPDR S&P 500 ETF (SPY)
- AUM
- 4.66B
- Region
- North America
- Expense Ratio
- 0.34%
- Beta
- 1.00
- Issuer
- T. Rowe Price
- Inception Date
- Jun 08, 2021
- Dividend Yield
- 0.57%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
TSPA Summary
T. Rowe Price U.S. Equity Research ETF (TSPA) is a fund that invests across the whole U.S. stock market, using T. Rowe Price’s research instead of tracking a fixed index. It holds many types of companies, from smaller firms to giants like Apple and Nvidia, across sectors such as technology, finance, health care, and consumer businesses. Someone might invest in TSPA for broad diversification and long-term growth potential in U.S. stocks in a single, research-driven fund. A key risk is that it can rise or fall with the overall U.S. stock market, and it has a heavy tilt toward technology companies.
How much will it cost me?
TSPA has an expense ratio of 0.34%, which means you’ll pay about $3.40 per year for every $1,000 invested. This cost is a bit higher than many index ETFs because TSPA is actively managed, using T. Rowe Price’s research team to select and weight stocks rather than simply tracking a market index.
What would affect this ETF?
This U.S. total-market ETF is heavily tilted toward large technology and communication companies like Nvidia, Apple, Microsoft, and Alphabet, so strong demand for innovation, cloud computing, and artificial intelligence, along with a healthy U.S. economy, could boost future returns. On the other hand, rising interest rates, tighter regulations on big tech, or a broad U.S. stock downturn would likely hurt these major holdings and weigh on the fund’s performance.
TSPA Top 10 Holdings
TSPA is powered by a heavy dose of U.S. Big Tech and chip names, with Nvidia, Apple, and Microsoft steering the ship. Apple and Microsoft have been steadily rising, giving the fund a solid backbone, while Nvidia’s performance has been more mixed lately, adding some drama to the ride. Amazon is contributing modest gains, but Alphabet’s twin share classes have been lagging and acting like a brake on recent returns. AMD and Tesla bring extra semiconductor and growth flair, reinforcing the fund’s tech-heavy, all‑U.S. positioning.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 AAPL | Apple | 8.29% | $374.37M | $5.06T | 29.35% | 79Outperform |
 NVDA | Nvidia | 7.16% | $323.36M | $4.07T | -15.15% | 76Outperform |
 MSFT | Microsoft | 6.38% | $288.03M | $3.96T | 5.37% | 79Outperform |
 AMZN | Amazon | 4.15% | $187.18M | $2.93T | 9.05% | 71Outperform |
 GOOG | Alphabet Class C | 2.70% | $122.09M | $3.50T | -1.95% | 82Outperform |
 META | Meta Platforms | 2.31% | $104.39M | $1.64T | 1.52% | 76Outperform |
 GOOGL | Alphabet Class A | 2.19% | $98.72M | $3.50T | -0.94% | 85Outperform |
 AVGO | Broadcom | 2.12% | $95.90M | $1.58T | -7.37% | 76Outperform |
 LLY | Eli Lilly & Co | 1.71% | $77.33M | $1.35T | 48.17% | 72Outperform |
 JPM | JPMorgan Chase | 1.49% | $67.22M | $908.40B | 7.95% | 72Outperform |
TSPA Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For TSPA, the sentiment is Negative. The current price of 47.24 is below the 20-day moving average (MA) of 47.91, below the 50-day MA of 48.29, and above the 200-day MA of 46.13, indicating a neutral trend. The MACD of -0.40 indicates Positive momentum. The RSI at 44.50 is Neutral, neither overbought nor oversold. The STOCH value of 33.50 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSPA.
TSPA Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| TSPA | $47.24 | $52.00(10.08% Upside) | $4.66B | 0.34% | 74Outperform |
 QLTY | $44.26 | $52.79(19.27% Upside) | $7.37B | 0.50% | 75Outperform |
 AKRE | $60.27 | $71.43(18.51% Upside) | $4.96B | 0.98% | 68Neutral |
 DCOR | $83.21 | $100.93(21.30% Upside) | $3.66B | 0.14% | 72Outperform |
 FTHI | $23.02 | $27.70(20.31% Upside) | $2.55B | 0.75% | 70Neutral |
 APUE | $46.39 | $56.83(22.50% Upside) | $2.45B | 0.31% | 70Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TSPA | T. Rowe Price U.S. Equity Research ETF | 47.24 | 5.17 | 12.29% | |
| QLTY | GMO U.S. Quality ETF | 44.26 | 7.31 | 19.77% | |
| AKRE | Akre Focus ETF | 60.27 | -3.72 | -5.81% | |
| DCOR | Dimensional US Core Equity 1 ETF | 83.21 | 11.74 | 16.42% | |
| FTHI | First Trust BuyWrite Income ETF | 23.02 | 1.47 | 6.82% | |
| APUE | ActivePassive U.S. Equity ETF | 46.39 | 5.67 | 13.94% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.